Noxopharm Limited (ASX:NOX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0680
+0.0030 (4.62%)
At close: Mar 3, 2026

Noxopharm Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
0.091.552.323.0114.0126.8
Cash & Short-Term Investments
0.091.552.323.0114.0126.8
Cash Growth
-97.81%-33.01%-22.89%-78.53%-47.71%277.40%
Accounts Receivable
4.61---0.010
Other Receivables
-2.952.46.085.215.79
Receivables
4.612.952.46.085.215.8
Inventory
----1.150.31
Prepaid Expenses
0.040.080.040.070.460.07
Total Current Assets
4.754.584.779.1620.8332.97
Property, Plant & Equipment
000.010.010.220.48
Long-Term Investments
--2.010.965.4214.27
Other Long-Term Assets
----0.120.12
Total Assets
4.754.586.7810.1326.5947.85
Accounts Payable
1.290.450.650.450.810.96
Accrued Expenses
0.320.930.510.411.145.53
Short-Term Debt
4.252.48----
Current Portion of Leases
----0.160.23
Other Current Liabilities
-0.010.080.10.170.08
Total Current Liabilities
5.863.871.250.962.286.81
Long-Term Leases
-----0.12
Pension & Post-Retirement Benefits
0.020.020.040.090.190.15
Total Liabilities
5.883.891.291.062.487.08
Common Stock
74.6474.6474.6474.6474.6472.62
Retained Earnings
-76.49-74.65-70.07-72.06-58.8-40.33
Comprehensive Income & Other
0.720.70.936.58.298.49
Total Common Equity
-1.130.695.59.0724.1240.78
Shareholders' Equity
-1.130.695.59.0724.1240.78
Total Liabilities & Equity
4.754.586.7810.1326.5947.85
Total Debt
4.252.48--0.160.35
Net Cash (Debt)
-4.15-0.922.323.0113.8526.45
Net Cash Growth
---22.89%-78.28%-47.63%1159.30%
Net Cash Per Share
-0.01-0.000.010.010.050.10
Filing Date Shares Outstanding
292.29292.24292.24292.24292.24288.23
Total Common Shares Outstanding
292.29292.24292.24292.24292.24288.22
Working Capital
-1.110.713.528.218.5526.17
Book Value Per Share
-0.000.000.020.030.080.14
Tangible Book Value
-1.130.695.59.0724.1240.78
Tangible Book Value Per Share
-0.000.000.020.030.080.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.